Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
about
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsCerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatmentHIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentCerebrospinal fluid analysis in the HIV infection and compartmentalization of HIV in the central nervous systemPaving the path to HIV neurotherapy: Predicting SIV CNS diseaseHIV Associated Neurocognitive DisordersCompartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementiaClinical Trials in Neurovirology: Successes, Challenges, and PitfallsEvidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementiaConcentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological SymptomsGenetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis.Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells.Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.Neuropsychiatric manifestations of HIV infection and AIDSHIV-associated neurocognitive disorder.Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluidIndinavir population pharmacokinetics in plasma and cerebrospinal fluid. The HIV Neurobehavioral Research Center Group.Evolving character of chronic central nervous system HIV infection.HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS ProjectComparison of scales to evaluate the progression of HIV-associated neurocognitive disorder.Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables.Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyHIV-associated neurocognitive disorders and the impact of combination antiretroviral therapiesSelect resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatmentHIV-associated neurocognitive disorders: perspective on management strategiesCerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis.Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected SubjectsMeasles viral load may reflect SSPE disease progression.Impact of human immunodeficiency virus on neurocognition and risky behaviors in young adultsHuman immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicityMinocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study
P2860
Q24631745-FFF2F2C9-1242-4802-8208-FD297C187E93Q24814874-8E1B1E5C-3B8F-4B19-97B0-F824AE13CBA1Q26766448-0A4DCF43-C507-41CB-AF93-17813958DF66Q26801033-DB8E4002-EA82-4517-9825-CD9608A315BFQ26852969-60F82D33-0CEB-430C-AD84-2269173B508EQ27023968-EFC46F62-B5E2-48CE-A2A4-04092287AD36Q28475360-F6F73531-7A5A-449B-A2D1-080BE65CF765Q30250271-7EF1854C-E4AB-4803-8C31-C88E34BE2893Q30936809-D4E87E85-7ABD-41E3-8FBC-4DB4383F791CQ33181807-2806D194-596C-4663-9198-E31507B82D0EQ33283465-B148BDBE-BCDF-462E-B48C-D1520263C00CQ33311631-56A801FA-3D78-4A81-96F9-B0943C2B28BBQ33520347-A7BF9AB0-7834-41C9-B423-9B6106272645Q33699222-7676AA62-E645-4107-BBA7-B7F824C7FA20Q33712027-02BA9863-2788-450C-B1AA-1E186F25D60AQ33716348-16E736F4-ABA1-44DA-A56D-B0D7D0EE3FD7Q33825647-1761875C-E2A6-4F8E-864F-2DFAA52ACC39Q33843510-946FF960-8C82-44FB-A026-F4F34D86E514Q33863368-7280205F-0939-487F-8150-B1196884E418Q33868874-F0C68AE8-496F-4C59-BCEA-133E5D77807DQ33939729-4720D916-C3D2-41CA-8401-84D374CECA14Q33972048-C9557563-6752-4E2C-85E8-F7E11A2A02F0Q33980273-A19C1A5E-F24B-4BCD-AA16-15E540CDD8B5Q33995713-6CA747AC-07DB-4A0F-9C65-19394DD314B1Q34076133-296FBE55-1E74-4C5B-8974-E08A3BC8E5AAQ34103216-CCFF2E08-F233-4DF1-8BEC-6575779DB1CCQ34215731-7FF2A308-3914-469D-AF81-A5F5CE04B48AQ34309626-90814430-3E01-46EC-A61E-E6277BEECDBFQ34370880-E9584897-38E0-40F6-BC36-F4DFB45E694FQ34599414-93011A16-7E99-4A10-B2DB-2CB2249948FEQ34615228-DE1CCEC0-7E85-45A0-A96D-DB36400F02F0Q34644242-502A4372-49DD-40E5-89D1-2F0C5801E527Q34652590-8B9BCEC9-6E61-4771-B280-D927ECE3A9F1Q34776835-119B6FC3-920F-48AC-97C3-E520E817BBD7Q34791743-F928C484-703C-4BE6-94CE-D5823BE6C66DQ34792090-B497FA5D-7256-46AE-BFCC-9D7206286695Q34893901-1BFC2805-A735-4CCB-ABA2-454C1715B3C1Q35009103-FD900CF0-74C1-47D1-AAD5-F6316229ABF7Q35020086-9E45C8E8-9761-43B1-8DFC-31F8587F0735Q35052651-E9D6066F-01D8-4DF3-A1F7-B1BAAD535B59
P2860
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Cerebrospinal fluid human immu ...... avioral Research Center Group.
@en
Cerebrospinal fluid human immu ...... avioral Research Center Group.
@nl
type
label
Cerebrospinal fluid human immu ...... avioral Research Center Group.
@en
Cerebrospinal fluid human immu ...... avioral Research Center Group.
@nl
prefLabel
Cerebrospinal fluid human immu ...... avioral Research Center Group.
@en
Cerebrospinal fluid human immu ...... avioral Research Center Group.
@nl
P2093
P2860
P356
P1433
P1476
Cerebrospinal fluid human immu ...... avioral Research Center Group.
@en
P2093
Abramson I
Atkinson JH
McCutchan JA
Spector SA
Wallace MR
P2860
P304
P356
10.1002/ANA.410420503
P577
1997-11-01T00:00:00Z